These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22877433)

  • 21. Management of male osteoporosis: lessons for clinical practice.
    Cortet B; Biver E; Borg S; Chopin F; Hoppé E; Laroche M; Morel G; Razjbaum G; Roux C; Thomas T; Legrand E
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S208-10. PubMed ID: 22153672
    [No Abstract]   [Full Text] [Related]  

  • 22. Osteoporosis.
    Compston JE; McClung MR; Leslie WD
    Lancet; 2019 Jan; 393(10169):364-376. PubMed ID: 30696576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
    Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanisms of action of anticatabolic drugs used in osteoporosis therapy].
    Kryśkiewicz E; Lorenc RS
    Endokrynol Pol; 2009; 60(2):134-44. PubMed ID: 19396757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Osteoporosis in men receiving androgen deprivation therapy for non-metastatic prostate cancer].
    Kudlacek S; Puntus T
    Wien Med Wochenschr; 2012 Sep; 162(17-18):380-5. PubMed ID: 22875632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Denosumab: a novel antiresorptive drug for osteoporosis.
    Suresh E; Abrahamsen B
    Cleve Clin J Med; 2015 Feb; 82(2):105-14. PubMed ID: 25897599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causes, consequences, and treatment of osteoporosis in men.
    Banu J
    Drug Des Devel Ther; 2013; 7():849-60. PubMed ID: 24009413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.
    Shevroja E; Lamy O; Kohlmeier L; Koromani F; Rivadeneira F; Hans D
    J Clin Densitom; 2017; 20(3):334-345. PubMed ID: 28734710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal diseases in Cushing's syndrome: osteoporosis versus arthropathy.
    Kaltsas G; Makras P
    Neuroendocrinology; 2010; 92 Suppl 1():60-4. PubMed ID: 20829620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From Bench to Bedside: An Ounce of (Opportunistic) Prevention.
    Potter BK
    Clin Orthop Relat Res; 2018 Apr; 476(4):687-688. PubMed ID: 29481367
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer patients with fractures are rarely assessed or treated for osteoporosis: a population-based study.
    Leslie WD; Edwards B; Al-Azazi S; Yan L; Lix LM; Czaykowski P; Singh H
    Osteoporos Int; 2021 Feb; 32(2):333-341. PubMed ID: 32808139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacologic treatment of osteoporosis--2011].
    Lakatos P
    Orv Hetil; 2011 Aug; 152(33):1320-6. PubMed ID: 21824859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing Osteoporosis in COPD.
    Shen L; Lv J; Li J; Zhou J; Wang X
    Endocr Metab Immune Disord Drug Targets; 2024; 24(8):896-901. PubMed ID: 37711118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.
    Ferrari S; Reginster JY; Brandi ML; Kanis JA; Devogelaer JP; Kaufman JM; Féron JM; Kurth A; Rizzoli R
    Arch Osteoporos; 2016 Dec; 11(1):37. PubMed ID: 27800591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
    Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
    Osteoporos Int; 2010 Jan; 21(1):41-52. PubMed ID: 19705046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.
    Josse R; Khan A; Ngui D; Shapiro M
    Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of the safety and efficacy of risedronate for the treatment of male osteoporosis.
    Bobba R; Adachi JD
    Clin Interv Aging; 2007; 2(3):275-82. PubMed ID: 18044178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pharmacologic Management of Osteoporosis in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Danford CJ; Ezaz G; Trivedi HD; Tapper EB; Bonder A
    J Clin Densitom; 2020; 23(2):223-236. PubMed ID: 31146965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis in men: update 2011.
    Orwig DL; Chiles N; Jones M; Hochberg MC
    Rheum Dis Clin North Am; 2011 Aug; 37(3):401-14, vi. PubMed ID: 22023899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.